Impact of COVID-19 on oncology clinical trials
Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight | Journal of Medicinal Chemistry
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies - The Lancet Neurology
JCI Insight Impact Factor 2022 - Journal Impact Factor
Prognostic implications of neutrophil‐lymphocyte ratio in COVID‐19 - Jimeno - 2021 - European Journal of Clinical Investigation - Wiley Online Library
Journal of Clinical Epigenetics
JCI Insight Impact Factor 2022 - Journal Impact Factor
Journal of Clinical Epigenetics
Surgery Journal Impact Factor| Journal of Surgery Open Access
Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response - Gross - 2022 - British Journal of Clinical Pharmacology - Wiley Online Library
JCI Insight - Advertise in the JCI family of journals
JCI Insight Impact Factor 2022 - Journal Impact Factor
The immune landscape of SARS-CoV-2-associated Multisystem Inflammatory Syndrome in Children (MIS-C) from acute disease to recovery - ScienceDirect
Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications | Journal of Biomedical Science | Full Text
Neurosurgery Journals | journal name | open Access Journals
JCI Insight - Advertise in the JCI family of journals
JCI Insight Impact Factor 2022 - Journal Impact Factor
JCI Insight - About JCI Insight
Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study - The Lancet Microbe
JCEM Author Guidelines | The Journal of Clinical Endocrinology & Metabolism | Oxford Academic
Tourism and Hospitality | An Open Access Journal from MDPI
